The effects of the TRPV1 antagonist SB-705498 on TRPV1 receptor-mediated activity and inflammatory hyperalgesia in humans von Chizh, Boris A., O’Donnell, Mary B., Napolitano, Antonella, Wang, Jie, Brooke, Allison C., Aylott, Mike C., Bullman, Jonathan N., Gray, Emily J., Lai, Robert Y., Williams, Pauline M., Appleby, Jonathan M.

Volltext

Systemic Pharmacokinetics, Safety, and Preliminary Efficacy of Topical AhR Agonist Tapinarof: Results of a Phase 1 Study von Bissonnette, Robert, Vasist, Lakshmi S., Bullman, Jonathan N., Collingwood, Therese, Chen, Geng, Maeda‐Chubachi, Tomoko

Volltext

Characterising the plasma-target occupancy relationship of the neurokinin antagonist GSK1144814 with PET von Ridler, Khanum, Gunn, Roger N, Searle, Graham E, Barletta, Julien, Passchier, Jan, Dixson, Luanna, Hallett, William A, Ashworth, Sharon, Gray, Frank A, Burgess, Clare, Poggesi, Italo, Bullman, Jonathan N, Ratti, Emiliangelo, Laruelle, Marc A, Rabiner, Eugenii A

Volltext

Pharmacokinetics and central nervous system effects of the novel dual NK1/NK3 receptor antagonist GSK1144814 in alcohol‐intoxicated volunteers von te Beek, Erik T., Hay, Justin L., Bullman, Jonathan N., Burgess, Clare, Nahon, Kimberly J., Klaassen, Erica S., Gray, Frank A., Gerven, Joop M. A.

Volltext

The relative bioavailability of 2 prototype fixed-dose combination formulations for amlodipine and rosuvastatin in healthy white and Chinese subjects von Nwe, Htar H., Bullman, Jonathan N., Joshi, Shashidhar M., Stylianou, Annie, Kapsi, Shiva G.

Volltext

Pharmacokinetics and central nervous system effects of the novel dual NK 1 /NK 3 receptor antagonist GSK 1144814 in alcohol‐intoxicated volunteers von te Beek, Erik T., Hay, Justin L., Bullman, Jonathan N., Burgess, Clare, Nahon, Kimberly J., Klaassen, Erica S., Gray, Frank A., van Gerven, Joop M. A.

Volltext